KOO-KOO2's Recent Posts
Title Rating ▼ Company Posted on
Re: XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance 1 BIOASIS TECHNOLOGIES INC Nov 03, 2020 01:39PM
Re: RVV insider purchases 1 Resverlogix Corp. Dec 19, 2022 11:33AM
Re: Dr. Kausik Ray on BETonMACE 1 Resverlogix Corp. Dec 08, 2019 12:54PM
Re: Resverlogix Secures One-Year Extension of Maturity Date of Debenture 1 Resverlogix Corp. Jul 22, 2020 12:05PM
Re: MACE Event rate,.... 1 Resverlogix Corp. Mar 01, 2019 07:18AM
Re: Question about Phase 2 1 Resverlogix Corp. Mar 12, 2019 09:18AM
Re: Question on Rosuvastatin versus Astorvastatin 1 Resverlogix Corp. Sep 06, 2019 06:18PM
Re: Who'd a thunk.... 1 Resverlogix Corp. Oct 17, 2019 06:25PM
Re: The chart set up looks awesome imo.... 1 Resverlogix Corp. Dec 03, 2019 01:05PM
Re: What's the deal with Zenith? 1 Zenith Epigenetics Jun 23, 2023 07:48PM
Re: Block Trades-RVX 1 Resverlogix Corp. Jun 18, 2020 09:58AM
Re: A look at the competition. 1 Resverlogix Corp. May 17, 2021 04:17PM
Re: Bioasis to Host Annual General Meeting Webcast on December 5, 2019 1 BIOASIS TECHNOLOGIES INC Dec 08, 2019 01:44PM
Re: Maybe timing is everything… 1 Resverlogix Corp. Jun 05, 2023 08:09AM
Re: Financials 1 Zenith Epigenetics Apr 09, 2020 07:28PM
Re: why on earth 1 Resverlogix Corp. May 13, 2024 03:20PM
Struggle at the opening 1 Resverlogix Corp. Apr 24, 2019 09:39AM
Re: Technically we're very oversold... 1 Resverlogix Corp. Dec 17, 2019 03:44PM
Re: The latest numbers for Alberta. 1 Resverlogix Corp. Sep 17, 2021 11:15AM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial 1 Zenith Epigenetics May 20, 2024 01:50PM